Share: Facebook Twitter LinkedIn
Activity Provided By:


Pathways for Optimal Sequencing, Rapid Initiation, and Titration of Therapy in Patients with Heart Failure

Access Activity

Overview / Abstract:

Many patients with heart failure (HF) do not receive foundational treatment although these therapies reduce morbidity and mortality risks. The initiation and optimization of guideline-directed medical therapies (GDMT) can be challenging, but clinical practice guidelines and algorithms are available to assist.

Navigate through this interactive self-directed CME activity to apply the most recent clinical trial data and guidance to patient-specific factors seen in real-world practice. Expert perspectives and available evidence will help you implement GDMT in practice to improve patient quality of life, prevent rehospitalization, and reduce mortality risks in your patients with HF.


Jul 14, 2024


Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME


Online, Webinar / Webcast / Video

Credits / Hours

1.5 AMA PRA Category 1 Credit(s)


AMA PRA Category 1 Credit, MIPS improvement activity

Presenters / Authors / Faculty

Biykem Bozkurt, MD, PhD, FACC, FAHA, FHFSA, FACP
Senior Dean of Faculty, Baylor College of Medicine
The Mary and Gordon Cain Chair and Professor of Medicine
Director, Winters Center for Heart Failure Research
Assoc. Director, Cardiovascular Research Institute
Baylor College of Medicine
Houston, TX

Nihar R. Desai, MD, MPH
Associate Professor of Medicine
Vice Chief, Clinical Operations, Section of Cardiovascular Medicine
Investigator, Center for Outcomes Research and Evaluation
Yale School of Medicine
New Haven, CT

Sponsors / Supporters / Grant Providers

Supported by independent medical educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Keywords / Search Terms

ACHL Heart failure, HF, cardiology, American Heart Association, AHA, cardiovascular, CME, continuing medical education, B‐type natriuretic peptide, BNP, N‐terminal pro‐B‐type natriuretic peptide, NT‐proBNP, beta-blocker, MRA, ARNI, and an SGLT2 inhibitor, cardiologists, clinical nurse specialist, hospitalists, internists, primary care providers Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map